San Francisco - Alefacept (Amevive) offers efficacy for a broad spectrum of patients with chronic plaque psoriasis who are considered candidates for systemic therapy or phototherapy, according to the results of a retrospective study.
New Guidelines to Prevent Food Allergies in Pediatric Atopic Dermatitis Patients
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study
The Cutaneous Connection: JAK Inhibitor Safety for Treating AD
Indoor Tanning and Melanoma
Skin Barrier 101: Keep Up with What Your Patients Are Reading
2 Clarke Drive Cranbury, NJ 08512